Faster recovery in patients with facial nerve palsy treated with contralateral botulinum toxin injection: a case-control study.

IF 2.2 3区医学 Q2 OTORHINOLARYNGOLOGY

European Archives of Oto-Rhino-Laryngology Pub Date : 2025-07-01 Epub Date: 2025-02-18 DOI:10.1007/s00405-025-09247-6

Jung Mee Park, Ji Hyung Lim, Jae Sang Han, Shi Nae Park

{"title":"Faster recovery in patients with facial nerve palsy treated with contralateral botulinum toxin injection: a case-control study.","authors":"Jung Mee Park, Ji Hyung Lim, Jae Sang Han, Shi Nae Park","doi":"10.1007/s00405-025-09247-6","DOIUrl":null,"url":null,"abstract":"Purpose: Botulinum toxin (BTX, Botox) is increasingly used as an adjunct therapy to oral steroids in the management of facial paralysis, with positive outcomes. This study aimed to evaluate the additive effect of BTX injection on the non-paralyzed side and propose optimal injection timing for recovery time.Methods: A total of 48 atraumatic facial paralysis patients who visited Seoul St. Mary's hospital for facial palsy between June 2015 and May 2021 were retrospectively reviewed. Patients were divided into 2 groups: the BTX injection group (BG) and the non-BTX injection group (NBG). We analyzed the recovery rate of facial palsy to H-B grade II or lower in each group, and conducted telephone surveys to collect subjective satisfaction data after BTX injection.Results: Days of recovery to H-B grade II from symptom onset were 93.0 ± 62 and 68.7 ± 66.6 in NBG and BG, respectively. Early BTX injection (less than 17.5 days from symptom onset) was a prognostic factor for recovery to H-B grade II in less than 1 month (R2 = 0.935, B = 1.738, p < 0.001). Telephone survey showed subjective satisfaction in all aspects 1 month after BTX injection: function (83.3%), cosmetic (70.9%), and recovery (54.2%).Conclusion: Early contralateral facial BTX injection can shorten the recovery period of atraumatic facial palsy.","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":" ","pages":"3499-3505"},"PeriodicalIF":2.2000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Archives of Oto-Rhino-Laryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00405-025-09247-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Botulinum toxin (BTX, Botox) is increasingly used as an adjunct therapy to oral steroids in the management of facial paralysis, with positive outcomes. This study aimed to evaluate the additive effect of BTX injection on the non-paralyzed side and propose optimal injection timing for recovery time.

Methods: A total of 48 atraumatic facial paralysis patients who visited Seoul St. Mary's hospital for facial palsy between June 2015 and May 2021 were retrospectively reviewed. Patients were divided into 2 groups: the BTX injection group (BG) and the non-BTX injection group (NBG). We analyzed the recovery rate of facial palsy to H-B grade II or lower in each group, and conducted telephone surveys to collect subjective satisfaction data after BTX injection.

Results: Days of recovery to H-B grade II from symptom onset were 93.0 ± 62 and 68.7 ± 66.6 in NBG and BG, respectively. Early BTX injection (less than 17.5 days from symptom onset) was a prognostic factor for recovery to H-B grade II in less than 1 month (R² = 0.935, B = 1.738, p < 0.001). Telephone survey showed subjective satisfaction in all aspects 1 month after BTX injection: function (83.3%), cosmetic (70.9%), and recovery (54.2%).

Conclusion: Early contralateral facial BTX injection can shorten the recovery period of atraumatic facial palsy.

查看原文本刊更多论文

对侧注射肉毒杆菌毒素治疗面神经麻痹患者恢复更快：一项病例对照研究。

目的：肉毒杆菌毒素（BTX, Botox）越来越多地被用作口服类固醇治疗面瘫的辅助疗法，并取得了积极的结果。本研究旨在评估BTX注射对非麻痹侧的加性作用，并提出最佳的注射时间。方法：回顾性分析2015年6月至2021年5月在首尔圣玛丽医院就诊的48例非创伤性面瘫患者。患者分为两组：BTX注射组（BG）和非BTX注射组（NBG）。分析各组面瘫患者H-B级及以下恢复率，并进行电话调查，收集BTX注射后主观满意度数据。结果：NBG（93.0±62天）和BG（68.7±66.6天）从症状出现恢复到H-B级（II级）。早期注射BTX（症状出现后少于17.5天）是患者在1个月内恢复到H-B级的预后因素（R2 = 0.935, B = 1.738, p）。结论：早期对侧面部注射BTX可缩短非外伤性面瘫的恢复期。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Archives of Oto-Rhino-Laryngology 医学-耳鼻喉科学

CiteScore

5.30

自引率

7.70%

发文量

537

审稿时长

2-4 weeks

期刊介绍： Official Journal of European Union of Medical Specialists – ORL Section and Board Official Journal of Confederation of European Oto-Rhino-Laryngology Head and Neck Surgery "European Archives of Oto-Rhino-Laryngology" publishes original clinical reports and clinically relevant experimental studies, as well as short communications presenting new results of special interest. With peer review by a respected international editorial board and prompt English-language publication, the journal provides rapid dissemination of information by authors from around the world. This particular feature makes it the journal of choice for readers who want to be informed about the continuing state of the art concerning basic sciences and the diagnosis and management of diseases of the head and neck on an international level. European Archives of Oto-Rhino-Laryngology was founded in 1864 as "Archiv für Ohrenheilkunde" by A. von Tröltsch, A. Politzer and H. Schwartze.